Rapamycin ≥98% (by HPLC)

Supplier: ENZO LIFE SCIENCES

BMLA2750005 BMLA2750025
ENZOBMLA2750005EA 165 EUR
ENZOBMLA2750005 ENZOBMLA2750025
Rapamycin ≥98% (by HPLC)
Rapamycin

Macrocyclic-triene antibiotic possessing potent immunosuppressant activity. It forms a complex with FKBP12 that binds to an effector, thus inhibiting IL-2 and other growth promoting lymphokines. The effectors were identified as FRAP (FKBP12 rapamycin-associated protein) and RAFT1 (rapamycin and KFBP12 target). Rapamycin/FKBP complex does not inhibit FRAP PI 4-kinase activity, but does inhibit FRAP autophosphorylation. Rapamycin induces inhibition of p70s6k, p33cdk2 and p34cdc2. Selectively blocks signaling leading to the activation of p70/85 S6 kinase. Enhances apoptosis. Activator of autophagy both in vitro and in vivo.


  • Off-white or yellow solid


Soluble in chloroform, DMSO (25 mg/mL) or methanol


Packaging: Shipping temperature: Ambient

Formula: C₅₁H₇₉NO₁₃
Storage Temperature: Freezer
MDL Number: MFCD00867594
CAS Number: 53123-88-9

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR